More than 190 health systems have bought Doximity’s AI suite, while 16 of the 20 largest pharmaceutical companies have bought its AI Search advertising product, the report said, citing the company’s fiscal second-quarter earnings results.
The digital platform for medical professionals is moving beyond automated documentation into clinical decision support, positioning itself to capture pharmaceutical marketing dollars traditionally spent on search engines, according to the report.
Doximity’s health system customers grew from 165 to more than 190 in one quarter, including 10 of the nation’s top 20 hospitals, the report said. NewYork-Presbyterian has integrated its AI tools into electronic health records across 10 hospitals and hundreds of locations.
UC San Diego Health is among the first to adopt a patient context feature, which analyzes patient records, laboratory results and clinical notes to generate patient-specific answers and treatment guidance. Physicians using the feature write prompts averaging 12 words, down from 24, because the system automatically retrieves relevant information, according to the report.
The expansion comes as healthcare enterprises increase AI spending despite lengthy payback expectations. The PYMNTS Intelligence report “Enterprise AI Gains Ground, but Scale Remains Uneven” found in August that 84% expect to increase spending on new AI over the next 12 months, while 63% anticipate a five- to six-year payback period.
Hospitals are already seeing productivity gains from AI documentation, PYMNTS reported Sept. 25. AI scribes at The Permanente Medical Group recorded 2.5 million uses and saved physicians an estimated 15,700 hours, while Intermountain Health reduced documentation time by 27% among frequent users.
Moving into clinical decision support introduces greater risks. Doximity introduced DoseCheck after testing nine AI models and finding incorrect medication dosing recommendations in at least 2.3% of responses, according to an Oct. 29 press release from the company. About 44% of those errors were serious or potentially lethal.
Doximity also integrated Wolters Kluwer’s UpToDate’s medical reference content to improve clinical reliability, the Fierce Healthcare report said.
Its AI Search advertising product has reached eight-figure bookings, although that does not represent recognized revenue, according to the report. Doximity expects AI Search revenue to build gradually through 2027.
The company is targeting a larger market as physicians shift clinical searches to AI. U.S. pharmaceutical paid search spending totals about $14 billion annually, Doximity CEO Jeff Tangney said, per the report.
For all PYMNTS AI coverage, subscribe to the daily AI newsletter.
